Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twice-weekly aripiprazole for treating children and adolescents with tic disorder
IRCT201312263930N32Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aripiprazole in tic disorder, sponsored by Shiraz University of Medical Sciences. Started Jan 2014; status: completed.
02
Drugs
aripiprazole
03
Conditions
tic disorder
Beyond the preview
Go deeper on IRCT201312263930N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201312263930N32.